Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › SRM/MRM assay for the cyclin-dependent kinase inhibitor 2A (p16) protein

SRM/MRM assay for the cyclin-dependent kinase inhibitor 2A (p16) protein

US Patent 10620184 · Granted Apr 14, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Predicting optimal chemotherapy for CRC2020
OPRT expression and cancer treatment outcome2020
Quantifying MGMT protein for optimal cancer therapy of glioblastoma2020
Multiplex MRM assay for evaluation of cancer2020
Multiplex MRM assay for evaluation of cancer2020
SRM/MRM assay for the tyrosine-protein kinase receptor UFO(AXL) protein2020
SRM/MRM assay for the tyrosine-protein kinase receptor UFO(AXL) protein2020
Methods of treating lung cancer by predicting responders to cisplatin-pemetrexed2020
SRM/MRM assay for the fibroblast growth factor receptor 2 (FGFR2) protein2020
SRM/MRM assay for the fibroblast growth factor receptor 2 (FGFR2) protein2020
SRM/MRM assays for cancer2020
Truncated Her2 SRM/MRM assay2020